ASTH

Astrana Health Stock Analysis

AI Rating

Low
  • Quality7/10
  • Growth 0/10
  • Momentum 2/10
Astrana Health sales and earnings growth
ASTH Growth
Low
  • Revenue Y/Y 68.17%
  • EPS Y/Y -84.73%
  • FCF Y/Y 38.74%
Astrana Health gross and profit margin trends
ASTH Profitability
Good
  • Gross margin 10.30%
  • EPS margin 0.30%
  • ROIC 9.70%
Astrana Health net debt vs free cash flow
ASTH Risk
Good
  • Debt / Equity 2.0
  • Debt / FCF 6.4
  • Interest coverage 1.7

Astrana Health stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

More Medical Care Facilities stocks ↗